Seqstant

Teltow, Germany Founded: 2021 • Age: 5 yrs
Software for pathogen analysis and metagenomic diagnostics is provided.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Seqstant

Seqstant is a company based in Teltow (Germany) founded in 2021 by Tobias Loka and Henri Knobloch. Seqstant operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

  • Headquarter Teltow, Germany
  • Founders Tobias Loka, Henri Knobloch
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Seqstant Gmbh
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Seqstant

Investors in Seqstant

Seqstant has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Brandenburg Capital, Venture League and Saarbruecker 21.

All
Venture Fund
Investor Description Founded Year Domain Location
Investments are directed by Brandenburg Capital toward multiple sectors.
Locked Locked Locked
Venture League is engaged in facilitating startup investments through a collaborative investor network.
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for Seqstant

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Seqstant

Investments
Premium access

Investment portfolio details for Seqstant

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Seqstant

Premium access

Detailed financials for Seqstant

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Seqstant Comparisons

Seqstant Primary company
Description
Software for pathogen analysis and metagenomic diagnostics i...
Location
Teltow, Germany
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Seqstant

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Seqstant

Seqstant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
Locked Locked Locked
AI and cloud-powered software for stroke care coordination is developed.
Locked Locked Locked
AI-powered single cell classification and isolation technology for clinical research
Locked Locked Locked
Digital pathology software is developed for clinical and veterinary productivity.
Locked Locked Locked
AI-based pathology diagnostic software is provided for medical analysis.
Locked Locked Locked
AI-based tools for pathological image analysis are provided to labs.
Premium access

Detailed competitors of Seqstant

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Seqstant

Brandenburg Kapital invests in Seqstant
Majunke2 years ago
Premium access

Complete news archive for Seqstant

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seqstant

Seqstant was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Seqstant is headquartered in Teltow, Germany. It is registered at Teltow, Brandenburg, Germany.

Henri Knobloch is the current CEO of Seqstant. They have also founded this company.

Seqstant was founded in 2021 in Teltow, Germany, as a provider of software tools in the biotechnology sector focused on diagnostics. The flagship product, LiveGene, is utilized for real-time identification of pathogens and resistance genes, along with calculation of quality metrics. Operations center on metagenomic analysis to support clinical and research applications in pathogen detection.

Seqstant's top competitors include Aignostics, Deciphex and Pictor Labs.

Seqstant has 4 investors. Key investors include Brandenburg Capital, Venture League, Saarbruecker 21, and HPI Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available